Drugs / CLODIVAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05480462 | Dec 2022 → Mar 2024 | diphtheria, tetanus | IBSS Biomed S.A. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLODIVAC | “booster immunization with bivalent vaccine against tetanus and diphtheria CLODIVAC (IBSS BIOMED S.A.)” NCT05480462 ↗ |
| Modality | Vaccine | “bivalent vaccine against tetanus and diphtheria CLODIVAC” NCT05480462 ↗ |
| Route | Intramuscular | “administered intramuscularly into deltoid muscle” NCT05480462 ↗ |